EC Number |
Recommended Name |
Source Tissue |
Reference |
---|
1.1.1.278 | 3beta-hydroxy-5alpha-steroid dehydrogenase |
gastric mucosa |
- |
639086 |
2.3.1.142 | glycoprotein O-fatty-acyltransferase |
gastric mucosa |
- |
486323 |
2.3.1.23 | 1-acylglycerophosphocholine O-acyltransferase |
gastric mucosa |
- |
486621 |
2.3.2.13 | protein-glutamine gamma-glutamyltransferase |
gastric mucosa |
patients with Helicobacter pylori negative gastritis have higher t-TG activity than patients with healthy, unifected gastric mucosa |
759154 |
2.4.1.102 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase |
gastric mucosa |
- |
637988, 638138, 638281 |
2.4.1.146 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase |
gastric mucosa |
- |
488370, 638138 |
2.4.1.150 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase |
gastric mucosa |
dIGnT |
638567 |
2.4.1.155 | alpha-1,6-mannosyl-glycoprotein 6-beta-N-acetylglucosaminyltransferase |
gastric mucosa |
- |
706072 |
2.4.1.244 | N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase |
gastric mucosa |
- |
668749, 736917 |
2.4.1.41 | polypeptide N-acetylgalactosaminyltransferase |
gastric mucosa |
stomach fundus, 2fold lower activity than in colon, mono-glycosylates MUC5AC peptide |
489192 |
2.4.1.69 | type 1 galactoside alpha-(1,2)-fucosyltransferase |
gastric mucosa |
- |
489348 |
2.4.1.69 | type 1 galactoside alpha-(1,2)-fucosyltransferase |
gastric mucosa |
Se enzyme |
489360 |
2.4.1.92 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase |
gastric mucosa |
- |
686976 |
2.4.2.10 | orotate phosphoribosyltransferase |
gastric mucosa |
- |
686922 |
2.7.1.59 | N-acetylglucosamine kinase |
gastric mucosa |
- |
641694 |
2.7.11.31 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase |
gastric mucosa |
- |
706085 |
2.8.2.11 | galactosylceramide sulfotransferase |
gastric mucosa |
reduced expression of the enzyme in the gastric mucosa of chronic gastritis according to the severety of gastric inflammation |
692513 |
2.8.2.19 | triglucosylalkylacylglycerol sulfotransferase |
gastric mucosa |
- |
643819 |
2.8.2.20 | protein-tyrosine sulfotransferase |
gastric mucosa |
- |
645819, 645825 |
3.1.1.5 | lysophospholipase |
gastric mucosa |
- |
94397 |
3.1.1.55 | acetylsalicylate deacetylase |
gastric mucosa |
cytosol |
646023 |
3.1.1.67 | fatty-acyl-ethyl-ester synthase |
gastric mucosa |
ventricular, low activity |
646076 |
3.1.22.1 | deoxyribonuclease II |
gastric mucosa |
multiple isoforms |
134288 |
3.1.4.39 | alkylglycerophosphoethanolamine phosphodiesterase |
gastric mucosa |
- |
208394, 650814 |
3.2.1.17 | lysozyme |
gastric mucosa |
3 lysozymes c |
171045 |
3.2.1.52 | beta-N-acetylhexosaminidase |
gastric mucosa |
- |
393709 |
3.4.14.1 | dipeptidyl-peptidase I |
gastric mucosa |
activity of dipeptidyl-peptidase I increases significantly as compared to the normal gastric mucosa |
667005 |
3.4.17.20 | Carboxypeptidase U |
gastric mucosa |
TAFI is detected in gastric mucosal epithelial cells. The concentration of TAFI is correlated with the degree of gastric mucosal atrophy, inflammation, and disease activity |
698151 |
3.4.18.1 | cathepsin X |
gastric mucosa |
upregulation in gastric cancer compared to non-neoplastic mucosa. Patients with Helicobacter pylori gastritis show significantly higher cathepsin X mRNA (2.5fold) and protein (1.6fold) expression than Helicobacter pylori-negative partients |
666147 |
3.4.21.4 | trypsin |
gastric mucosa |
antral mucosa |
95444 |
3.4.21.75 | Furin |
gastric mucosa |
chief cells, coordinated decrease of pepsinogen, furin, and transforming growth factor beta |
-, 668750 |
3.4.21.B27 | proprotein convertase 7 |
gastric mucosa |
- |
671240 |
3.4.21.B3 | duodenase |
gastric mucosa |
- |
667764 |
3.4.21.B42 | hippostasin |
gastric mucosa |
- |
718041 |
3.4.22.38 | cathepsin K |
gastric mucosa |
inflamed gastric mucosa |
708572 |
3.4.22.56 | caspase-3 |
gastric mucosa |
- |
708405 |
3.4.22.B28 | calpain 8 |
gastric mucosa |
in the gastric epithelium |
665705 |
3.4.23.1 | pepsin A |
gastric mucosa |
- |
35005, 36729, 36735, 36740, 36746, 36765, 753325, 753632, 753865, 754466, 755572 |
3.4.23.2 | pepsin B |
gastric mucosa |
- |
755370, 95814 |
3.4.23.2 | pepsin B |
gastric mucosa |
production of pepsinogen |
668808 |
3.4.23.3 | gastricsin |
gastric mucosa |
- |
35012, 36846, 36851, 36855, 36866, 36867, 36868, 718005, 753134, 755465 |
3.4.23.34 | cathepsin E |
gastric mucosa |
- |
30779, 30780, 30782, 30784, 30785, 30788, 30789, 30791, 30794, 30797, 30798, 30800, 677973 |
3.4.23.4 | chymosin |
gastric mucosa |
- |
36877 |
3.4.23.5 | cathepsin D |
gastric mucosa |
- |
36947 |
3.4.24.17 | stromelysin 1 |
gastric mucosa |
clinical phenotypes with Helicobacter pylori infection are strongly related to inflammatory cytokines, MMP-3, and pepsinogen secretion |
701204 |
3.4.24.7 | interstitial collagenase |
gastric mucosa |
- |
95826 |
3.4.24.86 | ADAM 17 endopeptidase |
gastric mucosa |
- |
638980 |
4.1.1.17 | ornithine decarboxylase |
gastric mucosa |
analysis of expression of the cancer-related protein ornithine decarboxylase (ODC) in nontransformed gastric mucosa, relationship between expression level of the enzyme and mucosal proliferation, overview |
-, 747964 |
4.1.1.17 | ornithine decarboxylase |
gastric mucosa |
positive nuclei in the junction |
698322 |
4.1.1.22 | histidine decarboxylase |
gastric mucosa |
- |
4142, 4144, 4145, 4147, 4163 |
4.1.1.22 | histidine decarboxylase |
gastric mucosa |
the tumours are classified based on clinico-pathological criteria |
749421 |
4.2.1.1 | carbonic anhydrase |
gastric mucosa |
- |
33588 |
4.2.1.1 | carbonic anhydrase |
gastric mucosa |
low expression, carbonic anhydrase XIII |
679413 |
4.2.1.3 | aconitate hydratase |
gastric mucosa |
- |
698948 |
5.1.3.7 | UDP-N-acetylglucosamine 4-epimerase |
gastric mucosa |
- |
2421 |
5.1.3.7 | UDP-N-acetylglucosamine 4-epimerase |
gastric mucosa |
membrane |
2414 |
5.1.99.4 | alpha-methylacyl-CoA racemase |
gastric mucosa |
staining for alpha-methylacyl-CoA racemase is uniformly negative in samples negative for dysplasia and indefinite for dysplasia. In the groups of high-grade dysplasia and invasive intestinal-type adenocarcinoma, 76% and 34% of samples are positive for alpha-methylacyl-CoA racemase, respectively. Expression of alpha-methylacyl-CoA racemase is not correlated with location, Helicobacter pylori infection, or intestinal metaplasia |
692564 |
5.3.99.2 | Prostaglandin-D synthase |
gastric mucosa |
- |
705307 |
5.3.99.3 | prostaglandin-E synthase |
gastric mucosa |
- |
691635 |
5.6.2.2 | DNA topoisomerase (ATP-hydrolysing) |
gastric mucosa |
- |
714645 |
7.2.2.19 | H+/K+-exchanging ATPase |
gastric mucosa |
- |
654331, 656051, 672636, 686551, 697414, 699742, 711245, 734279, 751533 |